Cargando…
Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
Alongside positive and negative symptomatology, deficits in working memory, attention, selective learning processes, and executive function have been widely documented in schizophrenia spectrum psychosis. These cognitive abnormalities are strongly associated with impairment across multiple function...
Autores principales: | Waddington, John L., Zhen, Xuechu, O’Tuathaigh, Colm M. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000454/ https://www.ncbi.nlm.nih.gov/pubmed/32063853 http://dx.doi.org/10.3389/fphar.2019.01638 |
Ejemplares similares
-
Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021) -
Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
por: Waddington, John L.
Publicado: (2020) -
Translational Genetic Modelling of 3D Craniofacial Dysmorphology: Elaborating the Facial Phenotype of Neurodevelopmental Disorders Through the “Prism” of Schizophrenia
por: Waddington, John L., et al.
Publicado: (2017) -
Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models
por: Moran, Paula, et al.
Publicado: (2016) -
Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation
por: Xu, Yiliang, et al.
Publicado: (2015)